IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 139 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $7,407,000 | -4.1% | 484,465 | -0.4% | 0.01% | 0.0% |
Q3 2016 | $7,722,000 | +22.6% | 486,291 | +1.0% | 0.01% | +12.5% |
Q2 2016 | $6,298,000 | +30.6% | 481,700 | +9.3% | 0.01% | +33.3% |
Q1 2016 | $4,822,000 | -1.6% | 440,781 | +4.3% | 0.01% | 0.0% |
Q4 2015 | $4,900,000 | +11.8% | 422,802 | +0.5% | 0.01% | 0.0% |
Q3 2015 | $4,383,000 | -14.5% | 420,635 | -1.1% | 0.01% | 0.0% |
Q2 2015 | $5,129,000 | -2.9% | 425,274 | +28.8% | 0.01% | -14.3% |
Q1 2015 | $5,284,000 | +6.3% | 330,241 | +1.7% | 0.01% | 0.0% |
Q4 2014 | $4,973,000 | +17.1% | 324,609 | -1.0% | 0.01% | +16.7% |
Q3 2014 | $4,247,000 | -15.0% | 327,850 | +0.6% | 0.01% | -14.3% |
Q2 2014 | $4,997,000 | +38.1% | 325,941 | +11.0% | 0.01% | +40.0% |
Q1 2014 | $3,618,000 | +22.0% | 293,695 | +15.0% | 0.01% | +25.0% |
Q4 2013 | $2,966,000 | -4.2% | 255,457 | -2.3% | 0.00% | -20.0% |
Q3 2013 | $3,096,000 | +27.0% | 261,445 | +6.5% | 0.01% | +25.0% |
Q2 2013 | $2,437,000 | – | 245,394 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 16,390,000 | $183,240,000 | 17.56% |
HealthInvest Partners AB | 1,450,000 | $16,211,000 | 12.91% |
Healthcare Value Capital, LLC | 200,000 | $2,236,000 | 4.98% |
BRIDGER MANAGEMENT, LLC | 2,852,414 | $31,890,000 | 2.98% |
Camber Capital Management LP | 7,500,000 | $83,850,000 | 2.88% |
13D Management LLC | 658,017 | $7,357,000 | 2.72% |
Brown Capital Management | 20,170,126 | $225,502,000 | 1.68% |
Healthcare Value Capital, LLC | 50,000 | $559,000 | 1.24% |
Zebra Capital Management LLC | 59,122 | $661,000 | 0.73% |
PRICE MICHAEL F | 520,000 | $5,814,000 | 0.70% |